Pharmaron and AstraZeneca: working as one team to accelerate drug disovery

In June 2012, AstraZeneca established a partnership to deliver a significant amount of our drug discovery work through collaboration with Pharmaron, a leading R&D service provider based in China.

Our shared hope is that this will speed up the discovery of novel medicines that address unmet patient needs. Pharmaron works closely with our teams to deliver discovery services in chemistry, as well as in drug metabolism and pharmacokinetics (DMPK).



Related articles